FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.3  |  FHIR Version n/a  User: [n/a]

22974911000001109: Ruxolitinib 20mg tablets 56 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 18-Sep 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
75502101000001111 Ruxolitinib 20mg tablets 56 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
75502201000001116 Ruxolitinib 20mg tablets 56 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ruxolitinib 20mg tablets 56 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ruxolitinib 20mg tablets 56 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Ruxolitinib 20mg tablets 56 tablet Has VMP Ruxolitinib 20mg tablets true Inferred relationship Existential restriction modifier
Ruxolitinib 20mg tablets 56 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ruxolitinib 20mg tablets 56 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ruxolitinib 20mg tablets 56 tablet Has specific active ingredient Ruxolitinib phosphate false Inferred relationship Existential restriction modifier
Ruxolitinib 20mg tablets 56 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ruxolitinib 20mg tablets 56 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ruxolitinib false Inferred relationship Existential restriction modifier
Ruxolitinib 20mg tablets 56 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ruxolitinib true Inferred relationship Existential restriction modifier
Ruxolitinib 20mg tablets 56 tablet Has basis of strength substance Ruxolitinib true Inferred relationship Existential restriction modifier
Ruxolitinib 20mg tablets 56 tablet Has specific active ingredient Ruxolitinib phosphate true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Jakavi 20mg tablets (Novartis Pharmaceuticals UK Ltd) 56 tablet 4 x 14 tablets Is a True Ruxolitinib 20mg tablets 56 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start